Under the Microscope
Mar. 4, 2015

Frank J. Monek Memorial Scholarship
NSH is happy to announce a new $10,000 scholarship available for members and their educational endeavors. Frank founded Surgipath Medical Industries Inc. in 1976 and led the company as president and CEO. Frank was a visionary, an innovator, a leader and a mentor who was not afraid to take chances. He was a staunch supporter of State Histology Societies as well as the National Society for Histotechnology and funded the Lee G. Luna Foreign Travel Scholarship Award. This new award is the first of its kind to be offered from a vendor and family members in the name of former vendor. Thanks to Cancer Diangostics Inc and Michelle & Andrea Monek for their sponsorship. Read more and apply today!More

CAP Inspection Webinar — Thursday, April 9
Join Kimberly Wayman, Flow Cytometry Manager at Laboratory Medicine Consultants present a webinar titled "How to Have a Successful CAP Inspection in the Flow Cytometry Laboratory." CAP recently created an All-Common checklist for Flow Cytometry to accompany the Flow Cytometry Checklist, both of which are now used during inspections. This session will highlight some of the more significant changes that were made. Register today!More

Histotechnology Professionals Day — March 10
Remember to celebrate your profession on Tuesday, March 10 and share with NSH! We offer items to order, contests to participate in and much more. Learn more on our website or become a fan of our Facebook page. Happy #histoday! More

Innovations in cell culture technology drive drug discovery studies
R&D Magazine
Scientists around the world make use of cell culture techniques on a daily basis. Whether they happen to be working with primary cell cultures, secondary cultures or cell lines, they all face many of the same problems: slow growth, spontaneous differentiation, evaporation, contamination and a host of other issues that require troubleshooting.More

Study shows safer methods for stem cell culturing
Lab Manager
A new study led by researchers at The Scripps Research Institute and the University of California, San Diego School of Medicine shows that certain stem cell culture methods are associated with increased DNA mutations. The study points researchers toward safer and more robust methods of growing stem cells to treat disease and injury.More

Common antidepressant may hold the key to heart failure reversal
Medical Xpress
A team led by researchers at Temple University School of Medicine found that a commonly prescribed antidepressant restored heart function in mice with heart failure, a finding that could lead to clinical trials for a disease long considered irreversible.More

10X Genomics unwraps its 'toaster oven' for better DNA sequencing
California-based 10X Genomics, which raised $55.5 million in venture capital recently, is providing its first technical look at the technology that drew the investment. The company and its scientific collaborators are discussing its method for assembling tough "long-read" stretches of DNA into whole genomes at the Advances in Genome Biology & Technology conference. Genome sequencing has gotten much faster and cheaper in recent years, but today's genomes still suffer from informational gaps. Part of the reason is technical. More

Florida rheumatologist: UnitedHealthcare's management program for clinical lab tests could jeopardize patient care
Dark Daily
In Florida, the confrontation between one of the nation's largest health insurance corporations and physicians, clinical laboratory managers and pathologists continues. The source of this confrontation are the restrictive and burdensome requirements for medical laboratory test ordering imposed last fall by UnitedHealthcare and administered by BeaconLBS, a business division of Laboratory Corporation of America. More

T-Tracks keeps tabs on clinical samples while in transit
Clinical lab specialists now have a new way of keeping track of samples as they travel from collection sites for pathology testing. Lab Sensor Solutions out of Redwood City, California has released a new system that keeps tabs on both the location and temperature of clinical samples while in transit.More

Metropolis' chain of diagnostics labs pushes for growth across India and Africa
Ameera Shah's earliest memory of work is summer internships at ages 9 and 10 at her father's pathology lab in Mumbai. She'd welcome clients, answer calls and write out receipts. Shah even recalls striding into dad's office one day and asking him to let her call him "sir" so that people wouldn't treat her like the boss' daughter. From that humble start Shah, 35, is now CEO, promoter and managing director of the $350 million Metropolis Healthcare. Since joining her doctor dad's pathology lab in 2001 she has expanded it from one lab with revenue of $1.5 million and about 40 employees into a multinational chain of 125 with $90 million in revenue and 4,500 employees. More

Blood samples reflect info from tumor biopsies in NSCLC
New findings show that it is feasible to determine epidermal growth-factor receptor mutations from the blood samples of patients with advanced non-small cell lung cancer and correlate them to clinical outcomes. The information is similar to that obtained from tumor tissue biopsies, but blood samples are obviously easier to obtain. The findings, from an analysis of the phase 3 European Erlotinib Versus Chemotherapy study, were published online in JAMA Oncology. More

FDA and WHO grant Corgenix emergency Ebola rapid diagnostic test use
Corginex Medical Corp., a company that develops and sells diagnostic test kits, recently received emergency use authorization from the Food and Drug Administration to use its ReEBOV™ Antigen Rapid Test to detect the Ebola virus in West Africa. It is the first rapid diagnostic test approved by the FDA and is also the first immunoassay that has gained approval. Because the RDT has also received approval from the World Health Organization, it is now available worldwide.More